Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
dorzolamide hydrochloride, Quantity: 22.3 mg/mL (Equivalent: dorzolamide, Qty 20 mg/mL)
Arrotex Pharmaceuticals Pty Ltd
Dorzolamide hydrochloride
Eye Drops, solution
Excipient Ingredients: benzalkonium chloride; water for injections; sodium hydroxide; hyetellose; sodium citrate dihydrate; mannitol
Ophthalmic
5 mL
(S4) Prescription Only Medicine
Dorzolamide eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Visual Identification: Slightly opalescent, colourless to nearly colourless, slightly viscous solution.; Container Type: Bottle; Container Material: LDPE; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Restricted flow insert
Licence status A
2017-01-17